These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 8042821)
1. Preserving renal function in patients with membranous nephropathy: daily oral chlorambucil compared with intermittent monthly pulses of cyclophosphamide. Reichert LJ; Huysmans FT; Assmann K; Koene RA; Wetzels JF Ann Intern Med; 1994 Sep; 121(5):328-33. PubMed ID: 8042821 [TBL] [Abstract][Full Text] [Related]
2. A randomized trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy. Ponticelli C; Zucchelli P; Passerini P; Cagnoli L; Cesana B; Pozzi C; Pasquali S; Imbasciati E; Grassi C; Redaelli B N Engl J Med; 1989 Jan; 320(1):8-13. PubMed ID: 2642605 [TBL] [Abstract][Full Text] [Related]
3. Oral cyclophosphamide versus chlorambucil in the treatment of patients with membranous nephropathy and renal insufficiency. Branten AJ; Reichert LJ; Koene RA; Wetzels JF QJM; 1998 May; 91(5):359-66. PubMed ID: 9709470 [TBL] [Abstract][Full Text] [Related]
4. A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy. Ponticelli C; Altieri P; Scolari F; Passerini P; Roccatello D; Cesana B; Melis P; Valzorio B; Sasdelli M; Pasquali S; Pozzi C; Piccoli G; Lupo A; Segagni S; Antonucci F; Dugo M; Minari M; Scalia A; Pedrini L; Pisano G; Grassi C; Farina M; Bellazzi R J Am Soc Nephrol; 1998 Mar; 9(3):444-50. PubMed ID: 9513907 [TBL] [Abstract][Full Text] [Related]
5. 20 years after methylprednisolone/chlorambucil treatment in idiopathic membranous nephropathy stage II-III with nephrotic syndrome. Polenakovic M; Grcevska L; Dzikova S Prilozi; 2006 Dec; 27(2):5-12. PubMed ID: 17211287 [TBL] [Abstract][Full Text] [Related]
6. Methylprednisolone plus chlorambucil as compared with methylprednisolone alone for the treatment of idiopathic membranous nephropathy. The Italian Idiopathic Membranous Nephropathy Treatment Study Group. Ponticelli C; Zucchelli P; Passerini P; Cesana B N Engl J Med; 1992 Aug; 327(9):599-603. PubMed ID: 1640953 [TBL] [Abstract][Full Text] [Related]
7. Sustained remission of membranous glomerulonephritis after cyclophosphamide and prednisone. Bruns FJ; Adler S; Fraley DS; Segel DP Ann Intern Med; 1991 May; 114(9):725-30. PubMed ID: 2012353 [TBL] [Abstract][Full Text] [Related]
8. Short- and long-term efficacy of oral cyclophosphamide and steroids in patients with membranous nephropathy and renal insufficiency. Study Group. Branten AJ; Wetzels JF Clin Nephrol; 2001 Jul; 56(1):1-9. PubMed ID: 11499653 [TBL] [Abstract][Full Text] [Related]
9. Treatment and long-term follow-up of patients with stage II to III idiopathic membranous nephropathy. Polenakovik MH; Grcevska L Am J Kidney Dis; 1999 Nov; 34(5):911-7. PubMed ID: 10561149 [TBL] [Abstract][Full Text] [Related]
10. Cytotoxic therapy for membranous nephropathy and renal insufficiency: improved renal survival but high relapse rate. du Buf-Vereijken PW; Branten AJ; Wetzels JF; Nephrol Dial Transplant; 2004 May; 19(5):1142-8. PubMed ID: 14993502 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of low-dose chlorambucil in nephrotic patients with idiopathic membranous nephropathy. Idasiak-Piechocka I; Oko A; Łochyńska-Bielecka K; Skrobańska B Kidney Blood Press Res; 2009; 32(4):263-7. PubMed ID: 19776643 [TBL] [Abstract][Full Text] [Related]
12. A randomized pilot trial comparing methylprednisolone plus a cytotoxic agent versus synthetic adrenocorticotropic hormone in idiopathic membranous nephropathy. Ponticelli C; Passerini P; Salvadori M; Manno C; Viola BF; Pasquali S; Mandolfo S; Messa P Am J Kidney Dis; 2006 Feb; 47(2):233-40. PubMed ID: 16431252 [TBL] [Abstract][Full Text] [Related]
13. Combination therapy with rituximab, low-dose cyclophosphamide, and prednisone for idiopathic membranous nephropathy: a case series. Cortazar FB; Leaf DE; Owens CT; Laliberte K; Pendergraft WF; Niles JL BMC Nephrol; 2017 Feb; 18(1):44. PubMed ID: 28143416 [TBL] [Abstract][Full Text] [Related]